Lumbosacral fasciitis
Conditions
Interventions
Spinal Pain Relief Group:Spinal Pain-Relieving Medicated Plaster for External Application
Placebo group:Topical placebo ointment (same base, without active pharmaceutical powder)
appearance, color, and odor consistent with the packaging
drug dosage is one-fourth of the regular Spintop group.
Compound Nanxian Pain-Relieving Plaster:Compound Nanxing Analgesic Plaster external application
Sponsors
Affiliated Suzhou City Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Participants who meet the clinical diagnostic criteria for "fasciitis of the lumbosacral region." (2) Patients with a traditional Chinese medicine (TCM) syndrome differentiation of wind-cold-damp arthralgia. (3) Individuals who have not received relevant interventions in the past 2 weeks (e.g., corticosteroid medications, long-term NSAIDs, etc.) to avoid interfering with the assessment of therapeutic effects. (4) Participants aged 18–65 years, with no restriction on gender. (5) Volunteers who agree to participate and sign the informed consent form, committing to follow-up visits as required and honestly reporting changes in their condition.
Exclusion criteria
Exclusion criteria: (1) With a history of other major diseases that can cause low back pain (e.g., urinary/reproductive system diseases, etc.) or severe cardiovascular, liver, or kidney dysfunction, or a history of tumors. (2) Pregnancy or lactation. (3) History of lumbar spine surgery or intraspinal injections. (4) Subjects expected to require surgery or other strong intervention during the trial period. (5) Scoliosis, spinal tumors, or inflammatory diseases. (6) Severe spinal degeneration (e.g., severe spinal stenosis, severe osteoarthritis, various cysts, etc.). (7) Severe allergy to Chinese herbal components or base materials, or a clear history of skin allergies. (8) Mental illness or inability to cooperate with follow-up and assessment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analog Scale;Oswestry Disability Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory markers;Magnetic Resonance;Infrared Thermography (IRT); | — |
Countries
China
Contacts
Public ContactYu Pengfei
Affiliated Suzhou City Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine
Outcome results
None listed